Evidence map›Paper›PMID 40036210›Full record

ArticlePloS one2025

Harmonizing and integrating the NCI Genomic Data Commons through accessible, interactive, and cloud-enabled workflows.

Ling-Hong Hung, Bryce Fukuda, Robert Schmitz, Varik Hoang, Wes Lloyd, Ka Yee Yeung

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ling-Hong HungSchool of Engineering and Technology, University of Washington Tacoma, Tacoma, Washington, USA.
Bryce FukudaSchool of Engineering and Technology, University of Washington Tacoma, Tacoma, Washington, USA.
Robert SchmitzSchool of Engineering and Technology, University of Washington Tacoma, Tacoma, Washington, USA.
Varik HoangSchool of Engineering and Technology, University of Washington Tacoma, Tacoma, Washington, USA.
Wes LloydSchool of Engineering and Technology, University of Washington Tacoma, Tacoma, Washington, USA.
Ka Yee YeungSchool of Engineering and Technology, University of Washington Tacoma, Tacoma, Washington, USA.ORCID 0000-0002-1754-7577

Funding

MorPhiC Data Resource and Administrative Coordinating CenterU24HG012674 · NHGRI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Helen Elizabeth Parkinson, Stephan C Schurer · 2022 to 2026
$6.9M
Intelligent deployment of containerized bioinformatics workflows on the cloudR01GM126019 · NIGMS · UNIVERSITY OF WASHINGTON · PI YEUNG-RHEE, KA YEE · 2018 to 2020
$1.1M
"HIGH THROUGHPUT SPATIALOMICS PROFILING FOR THICK TUMOR TISSUES"75N91021C00022 · NCI · BIODEPOT LLC · PI HOANG, VARIK · 2021 to 2021
$399k
SBIR Phase I Topic 407 - Cloud-Based Software for the Cancer Research Data Commons. 75N91020C00009 · NCI · BIODEPOT LLC · PI HUNG, LING-HONG · 2020 to 2020
$246k
Integrative and interactive analyses of host transcriptional response to COVID-19 and other respiratory viral infectionsR03AI159286 · NIAID · UNIVERSITY OF WASHINGTON · PI YEUNG-RHEE, KA YEE · 2022 to 2023
$155k
NCI NIH HHS 75N91020C00009NCI NIH HHS 75N91021C00022NHGRI NIH HHS U24 HG012674NIAID NIH HHS R03 AI159286NIGMS NIH HHS R01 GM126019
6 · The paper itself

Abstract

Cancer data is widely available in repositories such as the National Cancer Institute (NCI) Genomic Data Commons (GDC). These datasets could serve as controls or comparisons in compendium analyses with user data, avoiding the expense and time of generating additional datasets. However, the user must be able to process their new data in the same manner for these comparisons to be useful. This can be non-trivial. Although the executables themselves are usually available in repositories, the GDC pipelines that describe that entire analysis workflow are currently published as text-based standard operating procedures (SOPs). It is difficult to document a computational workflow to the level of detail and accuracy required to reproduce the results. Discrepancies between versions and exclusions of details accumulate as the documentation inevitably lags behind code revisions. Our goal is to enhance the utility of the GDC by converting the SOPs into an accessible and executable format. Specifically, we converted the GDC DNA sequencing (DNA-Seq) and the GDC mRNA sequencing (mRNA-Seq) SOPs into reproducible, self-installing, containerized, and interactive graphical workflows. These can be applied to reproducibly process user data and to harmonize datasets across repositories. Using our publicly available graphical workflows, we harmonize raw RNA-Seq datasets from the GDC and the Genotype-Tissue Expression (GTEx) project that were originally processed using different methodologies to illustrate the importance of uniform processing of control and treatment data for accurate inference of differentially expressed genes. By disseminating the analytical methodology in a reproducible and executable form, we greatly increase the utility of the GDC by enabling researchers to uniformly process custom data and datasets across multiple repositories to enhance data interpretation. Our approach and open-source executable workflows of making the analytical process as readily available as the data can be applied to other data repositories to increase their impact on scientific research.

Indexed as

Cloud ComputingDatabases, GeneticGenomicsNeoplasmsHumansNational Cancer Institute (U.S.)SoftwareUnited StatesWorkflow

Identifiers

PMID40036210
PMCPMC11878898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.